Role of Faecal Calprotectin in Patients With Abdominal Pain

Fondazione Policlinico Universitario Agostino Gemelli IRCCS146 enrolled

Overview

The evaluation of patients with abdominal pain is a challenge for the emergency physician and the selection of patients for second-level radiological examinations or endoscopic procedures is not always easy to perform. Faecal calprotectin could be a useful diagnostic marker to distinguish between "organic" or "functional" form and its determination could be helpful to select patients for further examinations, in the context of emergency setting.

Study Type

OBSERVATIONAL

Enrollment

146

Conditions

Inflammation

Interventions

calprotectin levelsDIAGNOSTIC_TEST

dosage of calprotectin levels in patients with abdominal pain

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with abdominal pain and/or diarrhea and/or rectal bleeding Exclusion Criteria: * patients with age \< 18 years * pregnant women; * patients with oncological, cardiological, nephrological terminal diseases; * patients on antibiotic therapy or who have taken it during the last month; * patients with a history of colic resection or gastrointestinal surgery; * patients with a previous diagnosis of inflammatory bowel disease (Crohn's disease, ulcerative colitis)

Locations (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, Italy

Outcomes

Primary Outcomes

inflammation

assess the degree of intestinal inflammation by fecal calprotectin assay in patients with abdominal pain

Time frame: 3 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.